Azithromycin Powder, For Suspension
Product Images NDC 63187-093

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 63187-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (4c093ab3 1599 4dec 8f7b 6d6b7fa233b2 01)

Chemical Structure (4c093ab3 1599 4dec 8f7b 6d6b7fa233b2 01)
Chemical structure of Azithromycin, depicted as a complex molecular diagram showing multiple rings, hydroxyl groups, and methyl groups typical of this macrolide antibiotic.*
FDA Label Image

63187-093-15 (4c093ab3 1599 4dec 8f7b 6d6b7fa233b2 02)

63187-093-15 (4c093ab3 1599 4dec 8f7b 6d6b7fa233b2 02)
Label for Azithromycin 200 mg/5 mL oral suspension, 15 mL bottle, relabeled by Proficient Rx LP. The label notes each 5 mL contains azithromycin monohydrate equivalent to 200 mg azithromycin USP, with storage instructions and manufacturer information: made in Croatia by PLIVA HRVATSKA d.o.o.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.